210) Thus, there is a need to further improve the treatment of work-rela |
211) To further investigate biological correlates |
212) To further investigate the association betwee |
213) essment techniques, should be employed to further investigate the impact of maternal |
214) noma (ADC) with a filigree pattern and to further investigate the relationship betwe |
215) Further validation demonstrated that umbil |
216) Further validation in multi-institution st |
217) Further validation studies have demonstrat |
218) Therefore, further validation of these results in a r |
219) second experiment with similar setup, and further confirmed in a third experiment us |
220) The aberrant AlaRS-Nrp1 interaction is further confirmed in patient samples carry |
221) ur data using machine learning techniques further confirmed our results: Classifying |
222) We further demonstrate how NST can be success |
223) GABRB2, LRP10, MSN, PLP1, and ATP6V1A We further demonstrate that variations betwee |
224) r motivating case study is carried out to further demonstrate the proposed methodolo |
225) We further demonstrated that mini-tLivin (MTV |
226) We further demonstrated that the normal assum |
227) We further demonstrated that these variants w |
228) We further highlight the potentials of precis |
229) al evaluation and computational modelling further highlight the role of gain-of-func |
230) We further highlight the vast array of possib |
231) It will further identify evidence gaps and future |
232) response to both T-DM1/P and THP and can further identify highly responsive HER2+ t |
233) th status of transnational mothers and to further identify issues for intervention a |
234) Further, in gene-gene interaction networks |
235) s of bacterial communities (β-diversity) further in females than males; and increas |
236) thways appeared to be dose-dependent upon further in vitro investigation. |
237) We further investigated acute changes of netw |
238) apering criteria and strategies should be further investigated. |
239) ctions among companion animals need to be further investigated. |
240) Further investigations of nutritional inte |
241) Further investigations of the interaction |
242) Further investigations using biomarkers of |
|